ChromaDex to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
02 Agosto 2023 - 7:02AM
Business Wire
ChromaDex Corp. (NASDAQ:CDXC), a global bioscience company
dedicated to healthy aging, announced that it will hold a
conference call on Wednesday, August 9, 2023 at 4:30 p.m. ET to
discuss its financial results for the second quarter, which ended
on June 30, 2023. The financial results will be reported in a press
release after the close of regular stock market trading hours on
the same day as the conference call.
Investor Conference Call:
ChromaDex management will host an investor conference call to
discuss second quarter 2023 results and provide a general business
update on Wednesday, August 9, at 4:30 p.m. ET.
Participants should call in at least 10 minutes prior. The
dial-in information is as follows:
Date: Wednesday, August 9, 2023 Time: 4:30 p.m. ET (1:30 p.m.
PT) Toll-free dial-in number: 1-888-330-2446 Conference ID: 4126168
Webcast link: ChromaDex Second Quarter 2023 Earnings Conference
Call
The conference call will be broadcast live and will be available
for replay here and via the investor relations section of the
Company’s website at www.chromadex.com.
A replay of the conference call will be available from 7:30 p.m.
ET on Wednesday, August 9, 2023, to 11:59 p.m. ET on Wednesday,
August 16, 2023.
Toll-free replay number: 1-800-770-2030 Replay ID: 4126168
About ChromaDex:
ChromaDex Corp. is a global bioscience company dedicated to
healthy aging. The ChromaDex team, which includes world-renowned
scientists, is pioneering research on nicotinamide adenine
dinucleotide (NAD+), levels of which decline with age. ChromaDex is
the innovator behind NAD+ precursor nicotinamide riboside (NR),
commercialized as the flagship ingredient Niagen®. Nicotinamide
riboside and other NAD+ precursors are protected by ChromaDex’s
patent portfolio. ChromaDex maintains a website at
www.chromadex.com to which ChromaDex regularly posts copies of its
press releases as well as additional and financial information
about the Company.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230802468732/en/
ChromaDex Media Contact: Kendall Knysch, Director of
Media Relations 310-388-6706 ext. 689
kendall.knysch@chromadex.com
ChromaDex Investor Relations Contact: 949-356-1620
InvestorRelations@chromadex.com
ChromaDex (NASDAQ:CDXC)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
ChromaDex (NASDAQ:CDXC)
Gráfica de Acción Histórica
De May 2023 a May 2024
